DSpace Repository

Genetic Association of Butyrylcholinesterase with Major Depressive Disorder

Show simple item record

dc.contributor.author Sliha Awan · Aisha N. Hashmi · Rizwan Taj · Sadaf Munir · Rabia Habib · Sajida Batool · Maleeha Azam · Raheel Qamar · Syed M. Nurulain
dc.date.accessioned 2026-01-05T04:03:16Z
dc.date.available 2026-01-05T04:03:16Z
dc.date.issued 2021
dc.identifier.uri http://hdl.handle.net/123456789/20352
dc.description Dr. Aisha Nasir Hashmi IPFP Fellow Research Cell BUCM en_US
dc.description.abstract Major depressive disorder (MDD) is characterized as clinical depression, which primarily affects the mood and behaviour of an individual. In the present study butyrylcholinesterase (BChE), a co-regulatory cholinergic neurotransmitter enzyme implicated in several putative neuronal and non-neuronal physiological roles was investigated for its role in MDD. Eighty MDD patients and sixty-one healthy controls were recruited for the study. BChE activity was measured by Ellman’s method using serum while DNA samples of the patients were genotyped for BCHE polymorphisms rs3495 (c.*189G > A) and rs1803274 (c.1699G > A) by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) and tetra-primer Amplification Refractory Mutation System- polymerase chain reaction (ARMSPCR). The genotyping was further validated by Sanger Sequencing. Biochemical estimation of serum BChE levels revealed a statistically significant decrease of enzyme activity in MDD patients (69.96) as compared to healthy controls (90.97), which was independent of age and gender. BCHE single nucleotide polymorphism rs1803274 genotype GA was found to be associated with the disease under a dominant model (OR 2.32; 95% CI 1.09–4.96; p value = 0.025). Furthermore, risk allele-A frequency was higher in cases (p value = 0.013) than control. Carriers of rs1803274 GA genotype showed reduced mean BChE activity than wild-type allele GG homozygotes (p value = 0.040). Gender-based analysis revealed a protective role of rs3495 in females (χ2 = 6.87, p value = 0.032, RM: OR 0.173, CI = 0.043–0.699 (p value = 0.017). In addition, rs1803274 risk allele-A was observed to be significantly higher in males (χ2 = 4.258, p value = 0.039). In conclusion, the present study is indicative of a role of BChE in the pathophysiology of MDD where genetic polymorphisms were observed to effect BChE activity. Further replication studies in different ethnicities are recommended to validate the current observations. en_US
dc.language.iso en en_US
dc.publisher Biochemical Genetics en_US
dc.subject Cholinergic neurotransmitter · Butyrylcholinesterase · Polymorphism association · Major depressive disorder en_US
dc.title Genetic Association of Butyrylcholinesterase with Major Depressive Disorder en_US
dc.type Article en_US


Files in this item

This item appears in the following Collection(s)

Show simple item record

Search DSpace


Advanced Search

Browse

My Account